Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GM-CSF for Neutrophil Function in Critically Ill Patients
NCT01653665Phase 2Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Aug 2012
- Primary completion
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in critical illness, sepsis, immunosuppression, sponsored by Newcastle Hospitals NHS Foundation Trust. Started Aug 2012; status: completed.
02
Drugs
sargramostim
03
Conditions
critical illnesssepsisimmunosuppression
Beyond the preview
Go deeper on NCT01653665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01653665.